Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barnes Retina Institute is a premier ophthalmology practice and clinical research center based in St. Louis, Missouri, specializing in the diagnosis and treatment of vitreoretinal diseases. Affiliated with the Washington University School of Medicine, the institute provides advanced surgical and medical care for conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. Beyond clinical practice, the institute is a globally recognized site for Phase 1 through Phase 3 clinical trials, contributing significantly to the development of modern retinal pharmacotherapies. Its team of fellowship-trained surgeons is actively involved in international research collaborations and academic education. The organization operates multiple clinical facilities across the St. Louis metropolitan area and Southern Illinois.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barnes Retina Institute.